Sudmantaitė Vaida, Čelutkienė Jelena, Glaveckaite Sigita, Katkus Rimgaudas
Clinic of Cardiac and Vascular Diseases, Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, Santariškių 2, LT-08661 Vilnius, Lithuania.
Eur Heart J Case Rep. 2020 Feb 13;4(1):1-6. doi: 10.1093/ehjcr/ytaa012. eCollection 2020 Feb.
Primary iron overload cardiomyopathy is an important and potentially preventable cause of heart failure (HF), usually manifesting in the 4-5th decade of life. Patients may be asymptomatic early in the disease with hidden progression of cardiac dysfunction. The challenge of timely detection is an awareness of this systemic disorder and an adequate degree of clinical vigilance.
A 48-year-old man was referred to the university clinic due to the episode of atrial fibrillation. The specific features of bronze skin and yellow eyes together with a combination of syndromes (cardiomyopathy, cirrhosis, ascites and portal hypertension, diabetes mellitus, and chronic kidney disease) stimulated the testing of iron metabolism markers, which were far above the normal range. Echocardiography and cardiac magnetic resonance (CMR) showed the dilatation of all cardiac cavities and biventricular systolic dysfunction. CMR T2* mapping was consistent with the diagnosis of myocardial and hepatic siderosis. Hereditary Type I haemochromatosis was confirmed by a genetic test. After 6 months of standard HF treatment, chelation therapy with deferiprone and regular phlebotomies imaging tests showed a reduction of ventricular and atrial volumes, an improvement in the cardiac systolic function and a decrease of iron accumulation.
In this case, complicating syndromes were detected earlier than underlying disease of primary haemochromatosis. Cardiac haemochromatosis should be considered in any patient with unexplained HF, especially in the case of a positive family history, abnormal liver enzymes, endocrinopathies, or evidence of involvement of other organ systems. Screening for systemic iron overload with transferrin saturation and serum ferritin is the first step. Further non-invasive imaging tests should be done to confirm organ involvement.
原发性铁过载心肌病是心力衰竭(HF)的一个重要且可能可预防的病因,通常在40至50岁出现。疾病早期患者可能无症状,心脏功能障碍呈隐匿性进展。及时检测的挑战在于认识这种全身性疾病并保持足够的临床警惕性。
一名48岁男性因房颤发作被转诊至大学诊所。青铜色皮肤和黄色眼睛的特殊体征,以及一系列综合征(心肌病、肝硬化、腹水和门静脉高压、糖尿病和慢性肾脏病)促使对铁代谢标志物进行检测,结果远高于正常范围。超声心动图和心脏磁共振成像(CMR)显示所有心腔扩大和双心室收缩功能障碍。CMR T2* 成像与心肌和肝脏铁沉积的诊断一致。基因检测确诊为遗传性I型血色素沉着症。经过6个月的标准HF治疗、去铁酮螯合治疗和定期放血,成像检查显示心室和心房容积减小、心脏收缩功能改善以及铁蓄积减少。
在本病例中,复杂综合征比原发性血色素沉着症的潜在疾病更早被发现。对于任何不明原因HF的患者,尤其是有阳性家族史、肝酶异常、内分泌病或其他器官系统受累证据的患者,都应考虑心脏血色素沉着症。用转铁蛋白饱和度和血清铁蛋白筛查全身性铁过载是第一步。应进一步进行非侵入性成像检查以确认器官受累情况。